ENTA
Enanta Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$14.08
+0.43%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 6.62x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 4.06x
- Price / sales
- 6.28x
- Price / cash flow
- -11.61x
Enterprise value
- Enterprise value
- $276.2M
- EV / sales
- 4.23x
- EV / EBITDA
- -5.94x
- EV / EBIT
- -4.70x
- Market cap
- $410.1M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026